Ignacio
Bernabeu Morón
Hospital General Universitario de Alicante
Alicante, EspañaPublicacións en colaboración con investigadores/as de Hospital General Universitario de Alicante (11)
2024
-
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433
2023
-
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly
Clinical Endocrinology, Vol. 99, Núm. 4, pp. 378-385
2022
-
Data mining analyses for precision medicine in acromegaly: a proof of concept
Scientific Reports, Vol. 12, Núm. 1
-
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
Biomedicines, Vol. 10, Núm. 2
2021
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
2020
-
Molecular profiling for acromegaly treatment: a validation study
Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389
2016
-
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
Pituitary, Vol. 19, Núm. 2, pp. 127-137
2014
-
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study
Clinical Endocrinology, Vol. 81, Núm. 6, pp. 883-890
2013
-
Changes in acromegaly treatment over four decades in Spain: Analysis of the Spanish Acromegaly Registry (REA)
Pituitary, Vol. 16, Núm. 1, pp. 115-121
2010
-
Introducción
Endocrinologia y Nutricion
2004
-
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)
European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 439-446